Mirae Asset Healthcare Fund Regular-Growth
Equity
Sectoral-Pharma
₹-0.22% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
- Rating
3 - Minimum Investment₹5000
- NAV (Net Asset Value)₹N/A
- AUM (Fund size)₹3556 Cr
- Created on1 July 2018
Fund Ranking
#5
/ 18 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
- 6 Month16.8%
- 1 Year17.9%
- 3 Year (CAGR)21.1%
- All Time (CAGR)20.5%
Category Return
- 6 Month16.2%
- 1 Year15.1%
- 3 Year (CAGR)20.7%
- All Time (CAGR)17.1%
Asset Allocation
- Equity99.7%
- Other0.3%
Top 5 Holdings
Top 5 Sectors
- Apollo Hospitals Enterprise5.91%
- Aurobindo Pharma3.81%
- Cipla2.71%
- Deepak Nitrite0.45%
- Dr. Reddy's Laboratories3.94%
Fund Information
- Expense Ratio2.04%
- Exit LoadExit load of 1% if redeemed within 1 Month.
- Lock-In PeriodNo Lock-In
Managed By
Vrijesh Kasera
June 2018 - Present
Tanmay Mehta
April 2025 - Present
Risk & Return Ratio
- Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance. 0.98 - Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment. 16.11 - Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance. -0.45 - Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility. 0.97